Leo, A.Samaranayake, S.F.Hodgkinson, J.D.Santorelli, C.Chandrasinghe, P.C.Warusavitarne, J.H.2023-05-302023-05-302016Colorectal Disease. 2016; 18(S1):521462-8910 (Print)1463-1318 (Electronic)http://repository.kln.ac.lk/handle/123456789/26350Poster Abstract (P050) of the 11th Scientific and Annual Meeting of the European Society of Coloproctology, September 28–30, 2016, Milan, ItalyAIM: Single Incision Laparoscopic Surgery (SILS) is a newer mini-invasive. Benefits of SILS in complex Crohn’s disease (CCD), which includes a significant cohort of young patients sometimes needing multiple operations has not been comprehensively assessed. This study analyses our early experience. METHOD: Data were collected prospectively from January 2013 to December 2015. Ileocolic resections, right hemicolectomy, small bowel stricturoplasties and resections SILS were included in the CCD cohort. Primary and re-do surgeries were analysed separately. RESULTS: A total of 45 patients were included: 39 ileocolic resections, 6 small bowel stricturoplasty/resections. Median hospital stay was 8 days (Range - 3 days – 28 days). Three patients from primary (11%) and 2 from re-do group (11%) had to be converted to open surgery. Total complication rate was 35.5% including 31.1% ClavienDindo 1 and 2. In term of operating time, average blood loss, conversion rates, complication rate and hospital stay, there was no significant difference between the groups. Six months follow-up showed no major complications. CONCLUSION: We have demonstrated the feasibility of SILS in patients with CCD. There were no significant differences between primary and re-do surgeries. More robust data and longer follow-up is needed in future studies to evaluate this further.enCrohn’s DiseaseCrohn’s Disease-surgeryLaparoscopyConference Abstract